Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
Early detection of cardiac damage is one of the most effective tools to prevent cardiovascular complications, improve prognosis, and preserve quality of life. Identifying alterations in the heart before symptoms appear allows for early intervention, treatment adjustments, and protection of cardiovascular health in both the short and long term. This approach is important for the […]
